These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16624955)

  • 1. Peripheral antinociceptive effects of exogenous and immune cell-derived endomorphins in prolonged inflammatory pain.
    Labuz D; Berger S; Mousa SA; Zöllner C; Rittner HL; Shaqura MA; Segovia-Silvestre T; Przewlocka B; Stein C; Machelska H
    J Neurosci; 2006 Apr; 26(16):4350-8. PubMed ID: 16624955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action.
    Horan PJ; Wild KD; Kazmierski WM; Ferguson R; Hruby VJ; Weber SJ; Davis TP; Fang L; Knapp RJ; Yamamura HI
    Eur J Pharmacol; 1993 Mar; 233(1):53-62. PubMed ID: 8386089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
    Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
    Stein C; Millan MJ; Shippenberg TS; Peter K; Herz A
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1269-75. PubMed ID: 2539460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociception produced by 14,15-epoxyeicosatrienoic acid is mediated by the activation of beta-endorphin and met-enkephalin in the rat ventrolateral periaqueductal gray.
    Terashvili M; Tseng LF; Wu HE; Narayanan J; Hart LM; Falck JR; Pratt PF; Harder DR
    J Pharmacol Exp Ther; 2008 Aug; 326(2):614-22. PubMed ID: 18492947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue.
    Schäfer M; Carter L; Stein C
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4219-23. PubMed ID: 7910403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antinociceptive properties of endomorphin-1 and endomorphin-2 in the mouse.
    Tseng LF
    Jpn J Pharmacol; 2002 Jul; 89(3):216-20. PubMed ID: 12184724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent inflammatory pain decreases the antinociceptive effects of the mu opioid receptor agonist DAMGO in the locus coeruleus of male rats.
    Jongeling AC; Johns ME; Murphy AZ; Hammond DL
    Neuropharmacology; 2009; 56(6-7):1017-26. PubMed ID: 19265713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia.
    Zhou L; Zhang Q; Stein C; Schäfer M
    J Pharmacol Exp Ther; 1998 Aug; 286(2):1000-6. PubMed ID: 9694961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mu/delta Cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat.
    Schmidt BL; Tambeli CH; Levine JD; Gear RW
    Eur J Neurosci; 2002 Mar; 15(5):861-8. PubMed ID: 11906528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L; Lee NM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
    Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of corticotropin-releasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain.
    Mousa SA; Bopaiah PC; Stein C; Schäfer M
    Pain; 2003 Dec; 106(3):297-307. PubMed ID: 14659512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin.
    Stein C; Gramsch C; Herz A
    J Neurosci; 1990 Apr; 10(4):1292-8. PubMed ID: 2158530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells.
    Brack A; Rittner HL; Machelska H; Leder K; Mousa SA; Schäfer M; Stein C
    Pain; 2004 Dec; 112(3):229-238. PubMed ID: 15561377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression.
    Brack A; Rittner HL; Machelska H; Shaqura M; Mousa SA; Labuz D; Zöllner C; Schäfer M; Stein C
    Pain; 2004 Mar; 108(1-2):67-75. PubMed ID: 15109509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
    Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
    Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
    Gouardères C; Jhamandas K; Sutak M; Zajac JM
    Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of β-endorphin in docosahexaenoic acid-induced antinociception.
    Nakamoto K; Nishinaka T; Ambo A; Mankura M; Kasuya F; Tokuyama S
    Eur J Pharmacol; 2011 Sep; 666(1-3):100-4. PubMed ID: 21658380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.